Cervavac, India's first indigenously developed vaccine for preventing cervical cancer caused by Human Papilloma Virus (HPV), is likely to be priced between Rs 200-400 per dose, Serum Institute of India (SII) CEO Adar Poonawala said on Thursday.
from Times of India https://ift.tt/jv8Xm1B
No comments:
Post a Comment